siRNA, Anti-FMO2, 2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT06574WQ-2OMe)

The product SIRGT06574WQ-2OMe is a type of small interfering RNA (siRNA) that targets FMO2 gene and regulates the expression of gene. The siRNA interferes with the expression of FMO2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001301347.1; NM_001460.4
Alternative Names FMO1B1
Related Diseases Trimethylaminuria, Prader-Willi Syndrome
Purification HPLC
Target Gene
Gene ID 2327
Uniprot ID Q99518
Sub Cat Target Species Modification Scale  
SIRGT08574WQ-2MOE FMO2 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT09574WQ-LNA FMO2 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT06574WQ-RB FMO2 Human Ribo-modified Inquiry
SIRGT07574WQ-BB FMO2 Human Backbone-modified Inquiry

Related Products